Kartesada

Pregabalin, the active ingredient in Kartesada, is a gabapentinoid presented as an oral tablet for oral administration. It modulates calcium channel activity and is used to treat neuropathic pain, partial seizures, and generalized anxiety disorder in adult patients.

GNH USA supplies Kartesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for global healthcare providers. The product complies with European Union pharmaceutical standards and is widely distributed across multiple regions.

Pregabalin is used to manage several neurological and pain‑related conditions.

- Diabetic peripheral neuropathy: reduces pain and improves sensory function in patients with diabetes‑related nerve damage. - Postherpetic neuralgia: alleviates lingering nerve pain following shingles. - Fibromyalgia: decreases widespread musculoskeletal pain and improves sleep quality. - Partial onset seizures: helps control focal seizures in epilepsy. - Generalized anxiety disorder: lessens anxiety symptoms and improves overall functioning.

Pregabalin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower limbs. - Weight gain: gradual increase in body weight.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue or throat. - Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or toxic epidermal necrolysis. - Suicidal thoughts: emergence or worsening of suicidal ideation.

When prescribing or dispensing pregabalin, several precautions should be observed to ensure patient safety. - Renal impairment: adjust dose in patients with reduced kidney function. - Suicidality risk: monitor for depression, suicidal thoughts, especially during treatment initiation. - Pregnancy: avoid use unless potential benefit justifies potential risk to fetus. - Elderly patients: start with lower dose and monitor for dizziness and falls. - Concomitant CNS depressants: use caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C, in original container, protect from moisture.

Pregabalin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Opioids: combined use may increase risk of respiratory depression and profound sedation. - CNS depressants (e.g., benzodiazepines, barbiturates): may cause excessive sedation or impaired cognition.

Moderate Interactions (Monitor Closely): - Antihypertensives: pregabalin may enhance hypotensive effects. - Diuretics: may increase risk of peripheral edema. - ACE inhibitors or ARBs: monitor renal function as combined effect may affect fluid balance.